Lanying Du

Summary

Affiliation: New York Blood Center
Country: USA

Publications

  1. doi request reprint Middle East respiratory syndrome: current status and future prospects for vaccine development
    Lanying Du
    a 1 Lindsley F Kimball Research Institute, New York Blood Center, NY, USA 1 212 570 3459
    Expert Opin Biol Ther 15:1647-51. 2015
  2. pmc A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
    Virol J 10:266. 2013
  3. pmc An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
    Virol J 7:151. 2010
  4. pmc Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
    Zhiliang Cao
    State Key Laboratory for Molecular Virology and Genetic Engineering, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
    Virol J 7:299. 2010
  5. pmc An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
    Virol J 7:9. 2010

Collaborators

  • Guangyu Zhao
  • Shibo Jiang
  • Bo Jian Zheng
  • Yusen Zhou
  • Shihui Sun
  • Zhiliang Cao
  • Yan Guo
  • Zhihua Kou
  • Vincent Km Poon
  • Ye Li
  • Lili Wang
  • Cuiqing Ma
  • Fei Yu
  • Lin Li
  • Yuchun Lone
  • Zhitao Ru
  • Yongping Lin
  • Yuxian He
  • Hong Yu
  • Wenjun Xiao
  • Chao Zhang
  • Lifeng Liu
  • Hongyan Sui
  • Taisheng Li
  • Jie Guan
  • Chris Cs Chan

Detail Information

Publications5

  1. doi request reprint Middle East respiratory syndrome: current status and future prospects for vaccine development
    Lanying Du
    a 1 Lindsley F Kimball Research Institute, New York Blood Center, NY, USA 1 212 570 3459
    Expert Opin Biol Ther 15:1647-51. 2015
    ....
  2. pmc A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
    Virol J 10:266. 2013
    ..In response, the development of effective vaccines and therapeutics remains a clinical priority. To accomplish this, it is necessary to evaluate neutralizing antibodies and screen for MERS-CoV entry inhibitors...
  3. pmc An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
    Virol J 7:151. 2010
    ..In this report, we investigated whether such M2e-MAP presenting the H5N1-M2e consensus sequence can afford heterosubtypic protection from lethal challenge with the pandemic 2009 H1N1 virus...
  4. pmc Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
    Zhiliang Cao
    State Key Laboratory for Molecular Virology and Genetic Engineering, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
    Virol J 7:299. 2010
    ..However, the antigenicity and immunogenicity of RBD in humans need to be characterized...
  5. pmc An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
    Guangyu Zhao
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
    Virol J 7:9. 2010
    ....